The Regulatory Review

49.9K posts

The Regulatory Review banner
The Regulatory Review

The Regulatory Review

@TheRegReview

Your daily source for regulatory news, analysis & commentary. From the Penn Program on Regulation at @Penn. RTs & links ≠ endorsements.

Philadelphia, PA Katılım Şubat 2011
2.7K Takip Edilen5.6K Takipçiler
The Regulatory Review
The Regulatory Review@TheRegReview·
In this week’s Saturday Seminar, scholars debate whether non-compete agreements should be regulated as anticompetitive restraints or preserved to protect legitimate business interests. buff.ly/O4co1V4
The Regulatory Review tweet media
English
0
1
1
111
The Regulatory Review
The Regulatory Review@TheRegReview·
In this week’s Saturday Seminar, scholars debate the legality, constitutional limits, and practical consequences of restricting gender-affirming care for transgender youth. buff.ly/A9uC359
The Regulatory Review tweet media
English
0
0
1
111
The Regulatory Review
The Regulatory Review@TheRegReview·
Interplanetary contamination and asteroid threats are outpacing existing space law, so new institutions should coordinate responses, argue Jonathan B. Wiener of @DukeLaw and Chase Hamilton. buff.ly/0f3F8gO
The Regulatory Review tweet media
English
0
1
1
113
The Regulatory Review
The Regulatory Review@TheRegReview·
Private funds may look safer than they are when managers smooth valuations, so the SEC should require clearer scenarios and fairer adviser incentives, argues Benjamin Bates of @Harvard_Law. buff.ly/AVo1YK6
The Regulatory Review tweet media
English
0
0
0
62
The Regulatory Review
The Regulatory Review@TheRegReview·
In a recent article, Jonathan B. Wiener of @DukeLaw and Chase Hamilton argue that expanding space activity creates interplanetary risks and call for coordinated risk regulation. buff.ly/0f3F8gO
The Regulatory Review tweet media
English
0
1
1
98
The Regulatory Review
The Regulatory Review@TheRegReview·
FDA may still win many post-Loper Bright cases if courts distinguish statutory interpretation from policymaking discretion, argues Erika Lietzan of @MizzouLaw. buff.ly/d9Fch52
The Regulatory Review tweet media
English
0
0
0
114
The Regulatory Review
The Regulatory Review@TheRegReview·
Retail investors may get the weakest slice of private markets unless the SEC requires clearer risk disclosures and simpler fund menus, argues Benjamin Bates of @Harvard_Law. buff.ly/AVo1YK6
The Regulatory Review tweet media
English
0
0
0
56
The Regulatory Review
The Regulatory Review@TheRegReview·
Opening private markets to retail investors may expose them to higher fees, higher risk, and weaker returns without stronger SEC guardrails, argues Benjamin Bates of @Harvard_Law. buff.ly/AVo1YK6
The Regulatory Review tweet media
English
0
0
0
88
The Regulatory Review
The Regulatory Review@TheRegReview·
Loper Bright shifts statutory interpretation from agencies to courts, but FDA’s technical policy decisions may still receive deferential review, argues Erika Lietzan of @MizzouLaw. buff.ly/d9Fch52
The Regulatory Review tweet media
English
0
0
0
81